Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

B-kompleks: En nutraceutisk SANS-modforanstaltning

9. november 2026 opdateret af: Sara R. Zwart, PhD, National Aeronautics and Space Administration (NASA)

In this project, the investigators propose to test effectiveness of a daily nutraceutical supplement containing bioactive B vitamins to mitigate optic disc edema in astronauts. The proposed countermeasure is intended to maximize functioning of the one-carbon metabolic pathway to provide enough substrate and cofactors to overcome any genetic differences that may impact the efficiency of enzyme function. By optimizing the pathway, this will 1) optimize endothelial function by increasing eNOS coupling and nitric oxide synthesis and 2) optimize collagen firmness and elasticity in the sclera and lamina cribrosa, and 3) minimize changes in total retinal thickness during and after flight.

The protocol includes assessments of ocular health and function, along with determinants of vascular endothelial function, advanced glycation end products, and nutritional status and one carbon biochemistry. These additional measures will be critical for the further definition of the causes of optic disc edema in some astronauts after long-duration space flight, and in understanding the effect of the countermeasure. Finally, the supplemented subjects in this study will be compared against total retinal thickness data from previously flown astronauts known to have not taken supplements during their missions.

Studieoversigt

Status

Rekruttering

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

Fasting (8-h) blood samples (7.5 mL SST and 5 mL EDTA tubes, 12.5 mL total per session) will be collected approximately 180 days and 45 days before flight, and return to Earth +0-2 days and 30 days after landing.

Blood samples will be analyzed for vitamin status and one-carbon biochemistry, as previously described. One blood sample (collected before flight) will be analyzed for approximately 511 SNPs matching the profile of testing from our ongoing research related to optic disc edema. Serum samples will be analyzed for biochemistry measures evaluating endothelial function, vitamin status, and oxidative damage.

Nutritional status assessment data, including inflight dietary intake and body mass data, completed for routine medical requirements will be requested for data sharing. Inflight medical exercise log data as well as available standard measures data will also be requested for data sharing. Medication use/Med Logs will also be requested for data sharing.

Vascular function VENDYS-II (Endothelix, Inc) will be used to assess reactive hyperaemia through changes in fingertip temperature. The test consists of an automated blood pressure measurement followed by cuff occlusion of the right arm for 2 to 5 min. During this time, the fingertip temperature in the right hand decreases because of the lack of circulation in the fingertip. After the cuff is released, blood flow resumes, causing a temperature rebound in the fingertip in a manner that is proportional to vascular reactivity.

Advanced Glycation End (AGE) Products Skin autofluorescence (SAF) will be analyzed non-invasively using an AGE reader (Diagnoptics Technologies, Groningen, the Netherlands). The AGE reader illuminates a skin surface of approximately 4 cm2, guarded against surrounding light, with an excitation light source with wavelength between 300 and 429 nm. This method is based on the fluorescent properties of certain AGEs accumulated in dermal tissue.

OCT and OCT-A Optical coherence tomography (OCT) and OCT-angiography (OCT-A) scans will be acquired using the Spectralis OCT2 (Heidelberg Engineering) before, during, and after flight. The scan pattern includes 24 B-scans centered in a radial pattern over the optic nerve head, as well as a 3.5 mm circle scan surrounding the optic nerve head for assessment of retinal nerve fiber layer thickness and choroid thickness. For OCT-A, five consecutive volume scans will be obtained in these regions, each containing 216 A-scans. These images will be registered, and the consecutive B-scans will be used to calculate the decorrelation among the images to provide split-spectrum amplitude decorrelation angiography (SSADA) images. This decorrelation between consecutive B-scan images will be used to highlight locations where there is blood flow. The density of the perfused peripapillary vessels within the various layers of the retina will be calculated to create a flow density map.

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

16

Fase

  • Fase 1

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

Studiesteder

    • Texas
      • Houston, Texas, Forenede Stater, 77058
        • Rekruttering
        • Johnson Space Center
        • Kontakt:
          • Eden Fields

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

20 år til 100 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

• Must be astronauts selected for 6-12 month missions on the International Space Station

Exclusion Criteria:

• Subjects taking B-vitamin supplements

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Forebyggelse
  • Tildeling: N/A
  • Interventionel model: Enkelt gruppeopgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Supplemented with B-Complex

Subjects will take a vitamin B-complex supplement before, during, and after a 6-12 month spaceflight on the International Space Station

Vitamin B-Complex Supplement containing: 5-methyltetrahydrofolate, riboflavin 5 phosphate, pyridoxal phosphate, and methylcobalamin

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Optic Disc Edema
Tidsramme: 6 months

Measure change in total retinal thickness during and after flight compared to preflight using OCT

6 months

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Endothelial function
Tidsramme: 6 months

Assess reactive hyperemia through changes in fingertip temperature

6 months
Advanced Glycation End Products (AGE)
Tidsramme: 6 months

Skin autofluorescence (SAF) will be analyzed non-invasively using an AGE reader

6 months
Serum folate status
Tidsramme: 6 months

Vitamin status assessed from a fasting blood sample

6 months
Red Blood Cell folate status
Tidsramme: 6 months

Vitamin status assessed from a fasting blood sample

6 months
Vitamin B6 status
Tidsramme: 6 months

Vitamin status assessed from a fasting blood sample

6 months
Vitamin B12 status
Tidsramme: 6 months

Vitamin status assessed from a fasting blood sample

6 months
Glucose
Tidsramme: 6 months

Serum glucose from a fasting blood sample

6 months
Nitric oxide
Tidsramme: 6 months

Serum nitric oxide from a fasting blood sample

6 months
tetrahydrobiopterin
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
Dihydrobiopterin
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
Oxidized glutathione
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
Total antioxidant capacity
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
Advanced glycation end products
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
Albumin
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
Glycated albumin
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
3-nitrotyrosine
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
Formate
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
MMP-2
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
MMP-9
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
TIMP-1
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
TIMP-2
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
Heparan sulfate
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
Syndecan-1
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
Glypican
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
Hyaluronan
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
Total lipid peroxides
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Samarbejdspartnere

Efterforskere

  • Ledende efterforsker: Sara R Zwart, PhD, UTMB

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. august 2022

Primær færdiggørelse (Anslået)

1. juli 2032

Studieafslutning (Anslået)

30. september 2035

Datoer for studieregistrering

Først indsendt

29. april 2022

Først indsendt, der opfyldte QC-kriterier

5. maj 2022

Først opslået (Faktiske)

9. maj 2022

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

12. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

9. november 2026

Sidst verificeret

1. november 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • NASA IRB STUDY00000448

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ja

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .